Journal article
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2—exploring RAS inhibitors
M Garg, SG Royce, JS Lubel
Alimentary Pharmacology and Therapeutics | WILEY | Published : 2020
DOI: 10.1111/apt.15814
Abstract
LINKED CONTENT This article is linked to Taxonera et al papers. To view these articles, visit https://doi.org/10.1111/apt.15804 and https://doi.org/10.1111/apt.15893.
Grants
Awarded by Pfizer
Funding Acknowledgements
The original study (Garg M, Royce SG, Tikellis C, et al Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut. 2020) was supported by a grant from the Broad Medical Research Program (Grant Reference IBD-0360).